ANI Pharmaceuticals
ANIP
ANIP
157 hedge funds and large institutions have $379M invested in ANI Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 170 → 157 (-13)
33% less call options, than puts
Call options by funds: $6.65M | Put options by funds: $9.9M
40% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 25
Holders
157
Holding in Top 10
1
Calls
$6.65M
Puts
$9.9M
Top Buyers
| 1 | +$15.5M | |
| 2 | +$15M | |
| 3 | +$4.61M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$4.09M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.64M |
Top Sellers
| 1 | -$9.8M | |
| 2 | -$6.68M | |
| 3 | -$3.96M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.7M |
| 5 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$3.46M |